Harbour Investments, Inc. Pliant Therapeutics, Inc. Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$14.58 - $20.15 $364 - $503	25 New	25 $0
Q4 2021 Feb 16, 2022	SELL	$12.27 - $18.26 $4,674 - $6,957	-381 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$16.48 - $28.98 $510 - $898	31 Added 8.86%	381 $6,000
Q2 2021 Aug 16, 2021	BUY	$28.05 - $37.69 $56 - $75	2 Added 0.57%	350 $10,000
Q1 2021 Aug 17, 2021	BUY	$24.52 - $40.23 $8,532 - $14,000	348 New	348 $14,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.